These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 163205)

  • 1. [Neurochemical and neurophysiological mechanisms of the psychostimulant action of phenamine].
    Arushanian EB
    Farmakol Toksikol; 1975; 38(1):111-20. PubMed ID: 163205
    [No Abstract]   [Full Text] [Related]  

  • 2. [Neurochemical and neurophysiological organization of phenamine behavioral stereotypy (review of the literature)].
    Arushanian EB
    Farmakol Toksikol; 1977; 40(2):221-30. PubMed ID: 404184
    [No Abstract]   [Full Text] [Related]  

  • 3. Proceedings: Brain monoamines and the increase in motor activity in the rat after amphetamine.
    Guldberg HC; Marsden CA
    Br J Pharmacol; 1972 Feb; 44(2):347P-348P. PubMed ID: 4668615
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of the d- and l-isomers of amphetamine on uptake, release and catabolism of norepinephrine, dopamine and 5-hydroxytryptamine in several regions of rat brain.
    Holmes JC; Rutledge CO
    Biochem Pharmacol; 1976 Feb; 25(4):447-51. PubMed ID: 938573
    [No Abstract]   [Full Text] [Related]  

  • 5. Mianserin, an antidepressant with a unique neuropharmacological profile.
    Leonard BE
    Acta Psychiatr Belg; 1978; 78(5):770-80. PubMed ID: 35926
    [No Abstract]   [Full Text] [Related]  

  • 6. Putative neurotransmitters in the brain: selective neuronal uptake, subcellular localization, and interactions with centrally acting drugs.
    Snyder SH
    Biol Psychiatry; 1970 Oct; 2(4):367-89. PubMed ID: 4320227
    [No Abstract]   [Full Text] [Related]  

  • 7. The action of (-) deprenyl on monoamine turnover rate in rat brain.
    Zsilla G; Knoll J
    Adv Biochem Psychopharmacol; 1982; 31():211-7. PubMed ID: 6805258
    [No Abstract]   [Full Text] [Related]  

  • 8. [Correlation of presynaptic components (uptake--release) in antidepressants].
    Dolzhenko AT
    Farmakol Toksikol; 1984; 47(5):22-5. PubMed ID: 6094236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacologic psychostimulation].
    Arushanian EB; Belozertsev IuA
    Farmakol Toksikol; 1978; 41(6):645-60. PubMed ID: 363450
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuropsychopharmacology of monoamines and their regulatory enzymes.
    Lipton MA
    Adv Biochem Psychopharmacol; 1974; 12(0):443-54. PubMed ID: 4153941
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies of bupropion's mechanism of antidepressant activity.
    Ferris RM; Cooper BR; Maxwell RA
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):74-8. PubMed ID: 6406468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A sensitizing d-amphetamine regimen induces long-lasting spinophilin protein upregulation in the rat striatum and limbic forebrain.
    Boikess SR; Marshall JF
    Eur J Neurosci; 2008 Nov; 28(10):2099-107. PubMed ID: 19046390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine and norepinephrine uptake by rat brain synaptosomes: relative inhibitory potencies of 1- and d-amphetamine and amantadine.
    Thornburg JE; Moore KE
    Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):81-9. PubMed ID: 4686111
    [No Abstract]   [Full Text] [Related]  

  • 14. Significance of dopamine receptor activity in dl-p-methoxyamphetamine- and d-amphetamine-induced locomotor activity.
    Tseng LF; Loh HH
    J Pharmacol Exp Ther; 1974 Jun; 189(3):717-24. PubMed ID: 4858403
    [No Abstract]   [Full Text] [Related]  

  • 15. Psychoactive drugs and neurotransmitters: differentiating dopamine and norepinephrine neuronal functions with drugs.
    Snyder SH; Taylor KM; Horn AS; Coyle JT
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():359-75. PubMed ID: 4341952
    [No Abstract]   [Full Text] [Related]  

  • 16. Amphetamine-induced locomotion, behavioral sensitization to amphetamine, and striatal D2 receptor function in rats with high or low spontaneous exploratory activity: differences in the role of locus coeruleus.
    Alttoa A; Eller M; Herm L; Rinken A; Harro J
    Brain Res; 2007 Feb; 1131(1):138-48. PubMed ID: 17156751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some aspects of the mechanism of action of various stimulant amphetamine analogues.
    Scheel-Krüger J
    Psychiatr Neurol Neurochir; 1972; 75(3):179-92. PubMed ID: 4402652
    [No Abstract]   [Full Text] [Related]  

  • 18. Antagonism of psychostimulant 2-phenyl-5,5-dimethyl-tetrahydro-1,4-oxazine hydrochloride (G 130) to central nervous system depressing drugs. Monoamine oxidase inhibitory activity and norepinephrine and serotonin induced changes. Comparison with dL-amphetamine.
    Fanelli O; Mazzoncini V; Trallori L
    Arzneimittelforschung; 1974 Dec; 24(12):2025-9. PubMed ID: 4480283
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine.
    Peterson DW; Sparber SB
    J Pharmacol Exp Ther; 1974 Dec; 191(3):349-57. PubMed ID: 4427285
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of carbaryl on catecholamines in brain regions.
    Ray SK; Haque SJ; Poddar MK
    Indian J Exp Biol; 1984 Mar; 22(3):141-4. PubMed ID: 6440860
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.